We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
EFC
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Liberty Latin America Class A
LILA
$1.46B
| – | – |
-33,035
| Closed | -$166K |
|
|
402
Liberty Latin America Class C
LILAK
$1.46B
| – | – |
-32,568
| Closed | -$221K |
|
403
Lindblad Expeditions
LIND
$1.87B
| – | – |
-13,431
| Closed | -$194K |
|
404
Lumentum
LITE
$65.2B
| – | – |
-1,445
| Closed | -$533K |
|
405
Eli Lilly
LLY
$1.05T
| – | – |
-260
| Closed | -$279K |
|
406
Lemonade
LMND
$5.27B
| – | – |
-5,152
| Closed | -$367K |
|
407
Cheniere Energy
LNG
$55B
| – | – |
-1,927
| Closed | -$375K |
|
408
El Pollo Loco
LOCO
$496M
| – | – |
-12,757
| Closed | -$133K |
|
409
LG Display
LPL
$3.26B
| – | – |
-40,512
| Closed | -$171K |
|
410
Lumen
LUMN
$6.96B
| – | – |
-14,916
| Closed | -$116K |
|
411
Las Vegas Sands
LVS
$30.1B
| – | – |
-9,682
| Closed | -$630K |
|
412
Lamb Weston
LW
$6.53B
| – | – |
-8,042
| Closed | -$337K |
|
|
LX
413
LexinFintech Holdings
LX
$237M
| – | – |
-104,360
| Closed | -$341K |
|
414
LSB Industries
LXU
$831M
| – | – |
-48,363
| Closed | -$411K |
|
415
Lyft
LYFT
$5.77B
| – | – |
-25,934
| Closed | -$502K |
|
416
LegalZoom.com
LZ
$1.26B
| – | – |
-23,397
| Closed | -$232K |
|
417
La-Z-Boy
LZB
$1.57B
| – | – |
-8,153
| Closed | -$304K |
|
418
Manchester United
MANU
$3.87B
| – | – |
-27,774
| Closed | -$442K |
|
419
Masco
MAS
$15.5B
| – | – |
-5,566
| Closed | -$353K |
|
420
Mativ Holdings
MATV
$445M
| – | – |
-20,409
| Closed | -$248K |
|
421
MediaAlpha
MAX
$767M
| – | – |
-34,034
| Closed | -$441K |
|
422
MBIA
MBI
$321M
| – | – |
-11,375
| Closed | -$81.4K |
|
423
McKesson
MCK
$97B
| – | – |
-260
| Closed | -$213K |
|
424
Marcus Corp
MCS
$727M
| – | – |
-12,338
| Closed | -$191K |
|
425
Mercury Insurance
MCY
$5.86B
| – | – |
-2,568
| Closed | -$242K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
T
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.